Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation (Q42502890)

1 November 2017

Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation (English)

1 reference

1 November 2017

1 reference

Bhanu P Pappu

1

1 reference

PubMed ID

17048267

1 November 2017

Xin Lin

series ordinal

2

1 reference

PubMed ID

17048267

1 November 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

European Journal of Immunology

1 November 2017

1 reference

1 November 2017

36

1 reference

1 November 2017

11

1 reference

1 November 2017

3033-3043

1 reference

Rapid response of marginal zone B cells to viral particles

1 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Signaling in transitional type 2 B cells is critical for peripheral B-cell development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Marginal-zone B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Marginal zone B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

IkappaB kinase alpha is essential for mature B cell development and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Development and selection of marginal zone B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Nuclear factor kappa B is required for the development of marginal zone B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Immunodeficiency in protein kinase cbeta-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

A requirement for CARMA1 in TCR-induced NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

The MAGUK family protein CARD11 is essential for lymphocyte activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Phosphorylation of the CARMA1 linker controls NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

CD40/CD154 interactions at the interface of tolerance and immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Does CD40 ligation induce B cell negative selection?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Modulation of NF-kappaB activity by exchange of dimers.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

c-Rel is essential for B lymphocyte survival and cell cycle progression.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Involvement of cell cycle progression in survival signaling through CD40 in the B-lymphocyte line WEHI-231.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Prevention of B cell antigen receptor-induced apoptosis by ligation of CD40 occurs downstream of cell cycle regulation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Integrin-mediated long-term B cell retention in the splenic marginal zone.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Role for CD40-mediated activation of c-Rel and maintenance of c-myc RNA levels in mitigating anti-IgM-induced growth arrest

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Kinetics and signaling requirements of CD40‐mediated protection from B cell receptor‐induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

B cell receptor signal strength determines B cell fate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Evidence of marginal-zone B cell-positive selection in spleen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535663

7 January 2021

Identifiers

DOI

10.1002/EJI.200535663

1 reference

1 November 2017

1 reference

PubMed ID

17048267